台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    96.2
  • 漲跌
    ▼4.3
  • 漲幅
    -4.28%
  • 成交量
    1,404
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
智擎 (4162)籌碼相關-合庫-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/2605/1005/2406/0806/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0602/1602/2603/1003/2003/3004/019095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

合庫-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/31298.15297.7596.2001,7710.00%
2025/03/281101.502103.25100.50-11,752-0.06%
2025/03/271103.5000.00103.5011,7280.06%
2025/03/261104.501105.50104.5001,7230.00%
2025/03/211106.0000.00106.5011,7140.06%
2025/03/201106.002106.50106.00-11,713-0.06%
2025/03/192105.7500.00104.5021,7180.12%
2025/03/1400.001105.50105.00-11,713-0.06%
2025/03/111107.5000.00107.0011,6970.06%
2025/03/101106.001107.50107.0001,6860.00%
2025/03/074107.383107.00107.5011,6650.06%
2025/03/063112.501111.00111.0021,6470.12%
2025/03/052114.5025114.06115.50-231,645-1.40%
2025/03/0400.001112.00114.50-11,634-0.06%
2025/03/032112.7500.00112.5021,6200.12%
2025/02/275112.402113.00109.0031,5680.19%
2025/02/263115.674116.88115.50-11,553-0.06%
2025/02/1900.005109.50110.00-51,396-0.36%
2025/02/171112.001112.50112.5001,3970.00%
2025/02/131110.5000.00111.5011,4130.07%
2025/02/123110.002110.50112.0011,4080.07%
2025/02/113110.833110.83109.0001,3920.00%
2025/02/101119.0000.00118.5011,3370.07%
2025/02/074118.2512118.25120.50-81,351-0.59%
2025/02/0614120.392119.50119.00121,3290.90%
2025/02/051113.0013112.62113.00-121,194-1.00%
2025/01/2000.000.393.3093.60-0.31,279-0.02%
2025/01/0900.00195.3094.60-11,341-0.07%
2025/01/0700.001102.00101.50-11,275-0.08%
2024/12/16187.8000.0086.3011,2160.08%
2024/12/11190.8000.0090.6011,1930.08%
2024/12/10192.0000.0092.1011,1880.08%
2024/12/06294.40293.4093.3001,1800.00%
2024/12/04194.40194.8094.6001,1640.00%
2024/12/03294.55394.5794.40-11,161-0.09%
2024/12/02294.55394.5794.40-11,158-0.09%
2024/11/29197.0000.0097.5011,1360.09%
2024/11/28293.30192.3092.4011,1100.09%
2024/11/151101.001102.0099.9009890.00%
2024/11/141104.502105.50101.50-1971-0.10%
2024/11/131106.001107.00106.5009460.00%
2024/11/122100.251102.50104.0019160.11%
2024/11/081105.001104.50103.0008730.00%
2024/11/061102.001103.50102.5008260.00%
2024/11/0500.001103.00106.00-1782-0.13%
2024/11/041105.0000.00100.0017580.13%
2024/10/2900.001101.00100.50-1604-0.17%
2024/10/281100.001101.00102.0005760.00%
2024/10/250.397.4000.0097.400.35130.05%
2024/10/24198.3000.0098.3014940.20%
2024/10/1700.00189.7088.30-1469-0.21%
2024/10/1500.00190.2090.20-1483-0.21%
2024/09/30289.5500.0089.5025500.36%
2024/09/2700.00288.0087.80-2556-0.36%
2024/09/2600.00288.5086.60-2576-0.35%
2024/09/25389.4000.0088.2036090.49%
2024/08/22186.70187.8086.6007400.00%
2024/08/21387.0000.0086.6037460.40%
2024/08/07087.30186.7086.70-1794-0.13%
2024/08/0500.000.183.7083.00-0.1764-0.01%
2024/07/3100.000.193.5093.20-0.1736-0.01%
2024/07/19195.0000.0094.2017080.14%
2024/07/0900.002100.0096.30-2668-0.30%
2024/07/05097.0000.0097.5006250.00%
2024/07/0400.000.296.2096.00-0.2626-0.03%
2024/07/02198.8000.0097.8016230.16%
2024/07/01199.60198.50101.0006100.00%
2024/06/26197.8000.0097.6015760.17%
2024/06/20194.40195.1094.5006350.00%
2024/06/1700.00196.9095.50-1644-0.16%
2024/06/14195.8000.0095.3016550.15%
2024/06/13197.00196.7096.9006510.00%
2024/06/12195.30195.6094.8006380.00%
2024/06/11195.50496.0095.40-3636-0.47%
2024/06/061.192.7300.0091.101.16300.17%
2024/06/05192.7000.0092.9016320.16%
2024/06/04191.0000.0090.8016470.15%
2024/05/0900.00094.3093.3001,0720.00%
2024/04/2300.00190.3090.20-11,498-0.07%
2024/04/220.289.0000.0088.000.21,5120.01%
2024/04/180.192.0000.0093.600.11,5250.01%
2024/04/1600.00492.4091.00-41,557-0.26%
2024/04/0900.00297.9597.60-21,722-0.12%
2024/04/082100.0000.0099.1021,7700.11%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-28天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章
 
 
66小時16